ADMA Biologics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ADMA Biologics, Inc. on September 9, 2016. The filing serves to disclose upcoming investor presentations under Regulation FD (Item 7.01) and includes a slide presentation as an exhibit (Item 9.01).
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate events and does not contain financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces scheduled management presentations.
Guidance, Outlook, and Management Commentary
Management plans to present at two upcoming conferences:
- Rodman & Renshaw 18th Annual Global Investment Conference on September 13, 2016, at 3:00 PM ET.
- Ladenburg Thalmann 2016 Healthcare Conference on September 27, 2016, at 10:30 AM ET in New York, NY.
A slide presentation (Exhibit 99.1) is furnished with this report and is available on the company's website. The filing explicitly states that the information in this report and the exhibit is not "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
Key Facts for Investor Verification
- Verify the content of the slide presentation (Exhibit 99.1) on the company website for any forward-looking statements or operational updates.
- Note that the presentation materials are not incorporated by reference into other SEC filings unless expressly stated.
- Confirm the dates and times of the upcoming investor conferences for potential attendance or webcast access.